Increased dividend to $0.29 from $0.26 for shareholders of record on 12/10.

Medical conglomerate Baxter International (BAX) boosted its quarterly common dividend 12%, to 29 cents a share from 26 cents, for a 2.11% yield. Payouts have been ongoing since 1934, and this is Baxter's fourth increase since February 2007. Third-quarter net rose to 87 cents a share from 74 cents on flat sales of $3.15 billion. Big Board-listed Baxter was recently quoted at 55. Its 52-week range is 62.50 to 45.46.

Covered right premium and dividends. Also HN1N1 profit potential

Read more here.

Company I work for

"Baxter has climbed 4% this year, less than major U.S. indices. The stock trades at a price-to-earnings ratio of 16, a discount to the market and medical equipment makers. The shares offer a 1.8% dividend yield." Read more here.

24 months = $$$$$

So many of these are bordering on their 52-week lows from the bad old days. Others can't get out of their way even when the fundamentals are good: Baxter (BAX), Abbott (ABT), Bristol Myers (BMY).

On the vaccine side, companies like GlaxoSmithKline, Baxter(BAX) and Crucell(CRXL) stand to benefit, he said.

With double-digit earnings growth, a robust balance sheet and strong R&D efforts under way, Baxter could see its shares climb by nearly 20%, to 65, by year's end.

don't know where it's hitting next